Markus Raderer
- Oncology top 5%
- Lung Cancer Research Studies 21
- Pancreatic and Hepatic Oncology Research 8
- Neurology top 5%
- Neuroblastoma Research and Treatments 9
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 5
-
- Lymphoma Diagnosis and Treatment 9
-
- Gastric Cancer Management and Outcomes 5
-
- Neuroendocrine Tumor Research Advances 25
-
- Radiopharmaceutical Chemistry and Applications 4
- Co-authors
- Michael HejnaWerner ScheithauerAmir KurtaranP. AngelbergerRobert DudczakGerhard HamiltonGeorg‐Christian FunkVentzislav Petkov
- Journals
- Journal of Clinical Oncology (7 papers)European Journal of Cancer (5 papers)Oncology (4 papers)
- Partner nations
- AustriaUnited StatesGermany
In The Last Decade
Markus Raderer
62 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 82
- Oncology 598
- Neurology 328
- Genetics 212
- Pathology and Forensic Medicine 296
- Pulmonary and Respiratory Medicine 380
Countries citing papers authored by Markus Raderer
This map shows the geographic impact of Markus Raderer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Raderer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Raderer more than expected).
Fields of papers citing papers by Markus Raderer
This network shows the impact of papers produced by Markus Raderer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Raderer. The network helps show where Markus Raderer may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Markus Raderer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2023 | 4 | |
| 3 | 2022 | 8 | |
| 4 | 2016 | 2 | |
| 5 | 2013 | 95 | |
| 6 | 2008 | 5 | |
| 7 | 2008 | 47 | |
| 8 | 2005 | 21 | |
| 9 | 2003 | 249 | |
| 10 | 2002 | 5 | |
| 11 | 2002 | 4 | |
| 12 | 2001 | 39 | |
| 13 | 2001 | 21 | |
| 14 | 1999 | 16 | |
| 15 | 1998 | 4 | |
| 16 | 1998 | 84 | |
| 17 | 1998 | 10 | |
| 18 | 1997 | 7 | |
| 19 | 1995 | 1 | |
| 20 | 1993 | 4 |
About Markus Raderer
Markus Raderer is a scholar working on Oncology, Neurology and Epidemiology, having authored 62 papers that have together received 1.5k indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (25 papers), Lung Cancer Research Studies (21 papers), Neuroblastoma Research and Treatments (9 papers), Lymphoma Diagnosis and Treatment (9 papers), Pancreatic and Hepatic Oncology Research (8 papers), Chronic Lymphocytic Leukemia Research (5 papers), Gastric Cancer Management and Outcomes (5 papers) and Radiopharmaceutical Chemistry and Applications (4 papers). The work is most often cited by research in Oncology (598 citations), Neurology (328 citations) and Genetics (212 citations). Markus Raderer has collaborated with scholars based in Austria, United States and Germany. Frequent co-authors include Michael Hejna, Werner Scheithauer, Amir Kurtaran, P. Angelberger, Robert Dudczak, Gerhard Hamilton, Georg‐Christian Funk, Ventzislav Petkov, Leopold Stiebellehner and Karin Vonbank. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, Oncology, ESMO Open and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.